SCHEMBL86348

SCHEMBL86348

COC(=O)[C@@H](C)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL295130 1.00 — —
SCHEMBL765886 1.00 — —
Hydrochloric Acid SCHEMBL722401 0.97 — —
SCHEMBL7105090 0.80 SMN1; SMN2 (0.46) —
SCHEMBL28353496 0.80 TSHR (0.37) —
SCHEMBL24072865 0.80 SMN1; SMN2 (0.46) —
SCHEMBL1557617 0.80 SMN1; SMN2 (0.46) —
SCHEMBL6744299 0.79 — —
SCHEMBL12447225 0.79 — —
Methyl 2-Methylbutanoate SCHEMBL1195352 0.79 TDP1 (0.43) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 384 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102351901-A 25-hydroxy vitamin D2 series medicament side chain and its preparation method SHANGHAI HAOYUAN CHEMEXPRESS CO LTD 2012-02-15 — — CN claimed
JP-1261341-A — — None — — JP disclosed
JP-7112966-A — — None — — JP disclosed
JP-8165263-A — — None — — JP disclosed
US-12600711-B2 Triazacyclododecansulfonamide (TCD)-based protein secretion inhibitors KEZAR LIFE SCIENCES, INC. (US) 2026-04-14 — — US disclosed
US-12577217-B2 15-PGDH inhibitor KYORIN PHARMACEUTICAL CO., LTD. (JP) 2026-03-17 — — US disclosed
US-12545684-B2 CDK2 inhibitors BLUEPRINT MEDICINES CORPORATION (US) 2026-02-10 — — US disclosed
US-20260034106-A1 Macrocyclic ligands for FK506-binding proteins for treatment of diseases with improved characteristics UNIV DARMSTADT TECH (DE) 2026-02-05 — — US disclosed
EP-4686495-A1 MACROCYCLIC LIGANDS FOR FK506-BINDING PROTEINS FOR TREATMENT OF DISEASES WITH IMPROVED CHARACTERISTICS Technische Universität Darmstadt (DE) 2026-02-04 — — EP disclosed
EP-4646416-A1 CDK2 INHIBITORS Blueprint Medicines Corporation (US) 2025-11-12 — — EP disclosed
EP-0480708-A2 Hydroxyalkylquinoline ether acids as leukotriene antagonists MERCK FROSST CANADA INC. (CA) 1992-04-15 — — EP disclosed
US-5081152-A AZULENE DERIVATIVES AS THROMBOXANE A2 AND PROSTAGLANDIN ENDOPEROXIDE RECEPTOR ANTAGONIST KOTOBUKI SEIYAKU CO., LTD. (JP) 1992-01-14 — — US disclosed
EP-0251408-B1 NOVEL ANTI-INFLAMMATORY AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR REDUCING INFLAMMATION THE PROCTER & GAMBLE COMPANY (US) 1991-04-17 — — EP disclosed
EP-0398474-A2 Oxazole derivatives and intermediates for their preparation MERCK & CO. INC. (US) 1990-11-22 — — EP disclosed
EP-0389244-A1 Process for synthesis of FK-506 C10-C18 intermediates MERCK & CO. INC. (US) 1990-09-26 — — EP disclosed
US-4946999-A Novel intermediates for synthesis of trichostatic acid or trichostatin A, and processes for preparing trichostatic acid and trichostatin A JAPAN TOBACCO INC. (JP) 1990-08-07 — — US disclosed
JP-H01261341-A PREPARATION OF OPTICALLY ACTIVE ALCOHOL NISSHIN FLOUR MILLING CO LTD 1989-10-18 — — JP disclosed
EP-0331524-A2 Synthesis of trichostatins Japan Tobacco Inc. (JP) 1989-09-06 — — EP disclosed
EP-0251408-A1 Novel anti-inflammatory agents, pharmaceutical compositions and methods for reducing inflammation THE PROCTER & GAMBLE COMPANY (US) 1988-01-07 — — EP disclosed
US-4708966-A SUBSTITUTED DI-TERT-BUTYL PHENOL DERIVATIVES THE PROCTER & GAMBLE COMPANY (US) 1987-11-24 — — US disclosed
Send feedback